VLL-28

General Information


DRACP ID  DRACP04774

Peptide Name   VLL-28

Sequence  VLLVTLTRLHQRGVIYRKWRHFSGRKYR

Sequence Length  28

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C163H264N54O35

Absent amino acids  ACDEMNP

Common amino acids  R

Mass  402199

Pl  12.51

Basic residues  10

Acidic residues  0

Hydrophobic residues  10

Net charge  10

Boman Index  -8039

Hydrophobicity  -57.5

Aliphatic Index  100.71

Half Life 
  Mammalian: >20 hour
  Yeast: >20 hour
  E.coli: ?

Extinction Coefficient cystines  8480

Absorbance 280nm  314.07

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30514888

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 28625421

Title  Not available

Doi Not available

Year  Not available

Literature 3

Pubmed ID 26338197

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  12244

DRACP is developed by Dr.Zheng's team.